{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:00:31Z","timestamp":1790182831846,"version":"4.1.0"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"DOI":"10.1038\/s41581-026-01123-8","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:02:18Z","timestamp":1790179338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of senescence in kidney ageing, injury and fibrosis"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-258X","authenticated-orcid":false,"given":"Piotr P.","family":"Janas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5857-4626","authenticated-orcid":false,"given":"Tilly","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9202-1428","authenticated-orcid":false,"given":"David A.","family":"Ferenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"1123_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","volume":"34","author":"KJ Jager","year":"2019","unstructured":"Jager, K. J. et al. A single number for advocacy and communication\u2014worldwide more than 850 million individuals have kidney diseases. Nephrol. Dial. Transplant. 34, 1803\u20131805 (2019).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1123_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae235","volume":"17","author":"Y Tang","year":"2024","unstructured":"Tang, Y., Jiang, J., Zhao, Y. & Du, D. Aging and chronic kidney disease: epidemiology, therapy, management and the role of immunity. Clin. Kidney J. 17, sfae235 (2024).","journal-title":"Clin. Kidney J."},{"key":"1123_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ekir.2024.01.034","volume":"9","author":"SK Jensen","year":"2024","unstructured":"Jensen, S. K., Heide-J\u00f8rgensen, U., Gammelager, H., Birn, H. & Christiansen, C. F. Acute kidney injury duration and 20-year risks of CKD and cardiovascular disease. Kidney Int. Rep. 9, 817\u2013829 (2024).","journal-title":"Kidney Int. Rep."},{"key":"1123_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126585","volume":"25","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Yu, C. & Li, X. Kidney aging and chronic kidney disease. Int. J. Mol. Sci. 25, 6585 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1123_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41581-025-00934-5","volume":"21","author":"L Abbad","year":"2025","unstructured":"Abbad, L., Esteve, E. & Chatziantoniou, C. Advances and challenges in kidney fibrosis therapeutics. Nat. Rev. Nephrol. 21, 314\u2013329 (2025).","journal-title":"Nat. Rev. Nephrol."},{"key":"1123_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cell.2013.10.019","volume":"155","author":"D Mu\u00f1oz-Esp\u00edn","year":"2013","unstructured":"Mu\u00f1oz-Esp\u00edn, D. et al. Programmed cell senescence during mammalian embryonic development. Cell 155, 1104\u20131118 (2013).","journal-title":"Cell"},{"key":"1123_CR7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4000","volume":"21","author":"BG Childs","year":"2015","unstructured":"Childs, B. G., Durik, M., Baker, D. J. & Deursen, J. M. van. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat. Med. 21, 1424\u20131435 (2015).","journal-title":"Nat. Med."},{"key":"1123_CR8","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1042\/CS20230140","volume":"137","author":"N Rex","year":"2023","unstructured":"Rex, N., Melk, A. & Schmitt, R. Cellular senescence and kidney aging. Clin. Sci. 137, 1805\u20131821 (2023).","journal-title":"Clin. Sci."},{"key":"1123_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb0203","volume":"13","author":"KJ Mylonas","year":"2021","unstructured":"Mylonas, K. J. et al. Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repair. Sci. Transl. Med. 13, eabb0203 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1123_CR10","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001855RR","volume":"35","author":"C Li","year":"2021","unstructured":"Li, C., Shen, Y., Huang, L., Liu, C. & Wang, J. Senolytic therapy ameliorates renal fibrosis postacute kidney injury by alleviating renal senescence. FASEB J. 35, e21229 (2021).","journal-title":"FASEB J."},{"key":"1123_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000599","volume":"18","author":"N Basisty","year":"2020","unstructured":"Basisty, N. et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18, e3000599 (2020).","journal-title":"PLoS Biol."},{"key":"1123_CR12","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.cub.2017.07.033","volume":"27","author":"A Hernandez-Segura","year":"2017","unstructured":"Hernandez-Segura, A. et al. Unmasking transcriptional heterogeneity in senescent cells. Curr. Biol. 27, 2652\u20132660.e4 (2017).","journal-title":"Curr. Biol."},{"key":"1123_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2026684118","volume":"118","author":"LMS Gerhardt","year":"2021","unstructured":"Gerhardt, L. M. S., Liu, J., Koppitch, K., Cipp\u00e0, P. E. & McMahon, A. P. Single-nuclear transcriptomics reveals diversity of proximal tubule cell states in a dynamic response to acute kidney injury. Proc. Natl Acad. Sci. 118, e2026684118 (2021).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1123_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/bs.irn.2020.03.019","volume":"155","author":"EOW Gerdes","year":"2020","unstructured":"Gerdes, E. O. W. et al. Chapter eight cellular senescence in aging and age-related diseases: implications for neurodegenerative diseases. Int. Rev. Neurobiol. 155, 203\u2013234 (2020).","journal-title":"Int. Rev. Neurobiol."},{"key":"1123_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2023.1327833","volume":"4","author":"F Milosic","year":"2024","unstructured":"Milosic, F., Hengstschl\u00e4ger, M. & Osmanagic-Myers, S. Premature aging in genetic diseases: what conclusions can be drawn for physiological aging. Front. Aging 4, 1327833 (2024).","journal-title":"Front. Aging"},{"key":"1123_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94097-5","volume":"11","author":"S Honda","year":"2021","unstructured":"Honda, S. et al. Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis. Sci. Rep. 11, 14608 (2021).","journal-title":"Sci. Rep."},{"key":"1123_CR17","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.5152\/eurjrheum.2023.22077","volume":"11","author":"N Surmachevska","year":"2023","unstructured":"Surmachevska, N. Harvard Medical School, Boston. Senescence in osteoarthritis: overview of mechanisms and therapeutics. Eur. J. Rheumatol. 11, S3\u2013S6 (2023).","journal-title":"Eur. J. Rheumatol."},{"key":"1123_CR18","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1038\/s41591-023-02543-w","volume":"29","author":"MM Gonzales","year":"2023","unstructured":"Gonzales, M. M. et al. Senolytic therapy in mild Alzheimer\u2019s disease: a phase 1 feasibility trial. Nat. Med. 29, 2481\u20132488 (2023).","journal-title":"Nat. Med."},{"key":"1123_CR19","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41593-024-01634-2","volume":"27","author":"T Ribierre","year":"2024","unstructured":"Ribierre, T. et al. Targeting pathological cells with senolytic drugs reduces seizures in neurodevelopmental mTOR-related epilepsy. Nat. Neurosci. 27, 1125\u20131136 (2024).","journal-title":"Nat. Neurosci."},{"key":"1123_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1124\/pharmrev.122.000622","volume":"75","author":"V Lucas","year":"2023","unstructured":"Lucas, V., Cavadas, C., Aveleira, C. A. & Hook, V. Cellular senescence: from mechanisms to current biomarkers and senotherapies. Pharmacol. Rev. 75, 675\u2013713 (2023).","journal-title":"Pharmacol. Rev."},{"key":"1123_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0092-8674(03)00401-X","volume":"113","author":"M Narita","year":"2003","unstructured":"Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703\u2013716 (2003).","journal-title":"Cell"},{"key":"1123_CR22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","volume":"25","author":"B Wang","year":"2024","unstructured":"Wang, B., Han, J., Elisseeff, J. H. & Demaria, M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat. Rev. Mol. Cell Biol. 25, 958\u2013978 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1123_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1242\/jcs.071340","volume":"124","author":"F Rodier","year":"2010","unstructured":"Rodier, F. et al. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J. Cell Sci. 124, 68\u201381 (2010).","journal-title":"J. Cell Sci."},{"key":"1123_CR24","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813\u2013827 (2019).","journal-title":"Cell"},{"key":"1123_CR25","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/febs.16361","volume":"290","author":"H Martini","year":"2023","unstructured":"Martini, H. & Passos, J. F. Cellular senescence: all roads lead to mitochondria. FEBS J. 290, 1186\u20131202 (2023).","journal-title":"FEBS J."},{"key":"1123_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.15252\/embj.201592862","volume":"35","author":"C Correia-Melo","year":"2016","unstructured":"Correia-Melo, C. et al. Mitochondria are required for pro-ageing features of the senescent phenotype. EMBO J. 35, 724\u2013742 (2016).","journal-title":"EMBO J."},{"key":"1123_CR27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","volume":"622","author":"S Victorelli","year":"2023","unstructured":"Victorelli, S. et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature 622, 627\u2013636 (2023).","journal-title":"Nature"},{"key":"1123_CR28","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.ekir.2025.04.035","volume":"10","author":"DP Baird","year":"2025","unstructured":"Baird, D. P. et al. Urinary clusterin is a biomarker of renal epithelial senescence and predicts human kidney disease progression. Kidney Int. Rep. 10, 2344\u20132356 (2025).","journal-title":"Kidney Int. Rep."},{"key":"1123_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature16932","volume":"530","author":"DJ Baker","year":"2016","unstructured":"Baker, D. J. et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature 530, 184\u2013189 (2016).","journal-title":"Nature"},{"key":"1123_CR30","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2147\/CIA.S256425","volume":"15","author":"SM Mir","year":"2020","unstructured":"Mir, S. M. et al. Shelterin complex at telomeres: implications in ageing. Clin. Interv. Aging 15, 827\u2013839 (2020).","journal-title":"Clin. Interv. Aging"},{"key":"1123_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1708","volume":"3","author":"G Hewitt","year":"2012","unstructured":"Hewitt, G. et al. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 3, 708 (2012).","journal-title":"Nat. Commun."},{"key":"1123_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s43587-021-00040-8","volume":"1","author":"S Saraswati","year":"2021","unstructured":"Saraswati, S., Mart\u00ednez, P., Gra\u00f1a-Castro, O. & Blasco, M. A. Short and dysfunctional telomeres sensitize the kidneys to develop fibrosis. Nat. Aging 1, 269\u2013283 (2021).","journal-title":"Nat. Aging"},{"key":"1123_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12030579","volume":"12","author":"T Levstek","year":"2023","unstructured":"Levstek, T. & Podkraj\u0161ek, K. T. Telomere attrition in chronic kidney diseases. Antioxidants 12, 579 (2023).","journal-title":"Antioxidants"},{"key":"1123_CR34","doi-asserted-by":"publisher","DOI":"10.1681\/asn.0000000771","author":"S Saraswati","year":"2025","unstructured":"Saraswati, S. et al. Telomere dysfunction in renal tubular epithelial cells leads to kidney fibrosis. J. Am. Soc. Nephrol. https:\/\/doi.org\/10.1681\/asn.0000000771 (2025).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1123_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2897","volume":"16","author":"MK Zeman","year":"2014","unstructured":"Zeman, M. K. & Cimprich, K. A. Causes and consequences of replication stress. Nat. Cell Biol. 16, 2\u20139 (2014).","journal-title":"Nat. Cell Biol."},{"key":"1123_CR36","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature05327","volume":"444","author":"RD Micco","year":"2006","unstructured":"Micco, R. D. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638\u2013642 (2006).","journal-title":"Nature"},{"key":"1123_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112474","volume":"399","author":"A Meller","year":"2021","unstructured":"Meller, A. & Shalgi, R. The aging proteostasis decline: from nematode to human. Exp. Cell Res. 399, 112474 (2021).","journal-title":"Exp. Cell Res."},{"key":"1123_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/jb\/mvae016","volume":"175","author":"J Hamazaki","year":"2024","unstructured":"Hamazaki, J. & Murata, S. Relationships between protein degradation, cellular senescence, and organismal aging. J. Biochem. 175, 473\u2013480 (2024).","journal-title":"J. Biochem."},{"key":"1123_CR39","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/febs.16249","volume":"289","author":"Y Takenaka","year":"2022","unstructured":"Takenaka, Y., Inoue, I., Nakano, T., Ikeda, M. & Kakinuma, Y. Prolonged disturbance of proteostasis induces cellular senescence via temporal mitochondrial dysfunction and subsequent mitochondrial accumulation in human fibroblasts. FEBS J. 289, 1650\u20131667 (2022).","journal-title":"FEBS J."},{"key":"1123_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112913","volume":"211","author":"Z Xie","year":"2025","unstructured":"Xie, Z., Zhang, X., Li, Y. & Zhu, R. Mitochondrial dysfunction drives cellular senescence: Molecular mechanisms of inter-organelle communication. Exp. Gerontol. 211, 112913 (2025).","journal-title":"Exp. Gerontol."},{"key":"1123_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cmet.2015.11.011","volume":"23","author":"CD Wiley","year":"2016","unstructured":"Wiley, C. D. et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 23, 303\u2013314 (2016).","journal-title":"Cell Metab."},{"key":"1123_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s44324-025-00067-0","volume":"3","author":"K Yusri","year":"2025","unstructured":"Yusri, K., Jose, S., Vermeulen, K. S., Tan, T. C. M. & Sorrentino, V. The role of NAD+ metabolism and its modulation of mitochondria in aging and disease. NPJ Metab. Health Dis. 3, 26 (2025).","journal-title":"NPJ Metab. Health Dis."},{"key":"1123_CR43","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.18632\/aging.102059","volume":"11","author":"G Castellano","year":"2019","unstructured":"Castellano, G. et al. Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4\/\u03b2catenin signaling after ischemia\/reperfusion injury. Aging 11, 4382\u20134406 (2019).","journal-title":"Aging"},{"key":"1123_CR44","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.tcb.2017.07.004","volume":"27","author":"Y Ito","year":"2017","unstructured":"Ito, Y., Hoare, M. & Narita, M. Spatial and temporal control of senescence. Trends Cell Biol. 27, 820\u2013832 (2017).","journal-title":"Trends Cell Biol."},{"key":"1123_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"J-P Copp\u00e9","year":"2010","unstructured":"Copp\u00e9, J.-P., Desprez, P.-Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Pathol. Mech. Dis. 5, 99\u2013118 (2010).","journal-title":"Pathol. Mech. Dis."},{"key":"1123_CR46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ncb3397","volume":"18","author":"M Hoare","year":"2016","unstructured":"Hoare, M. et al. NOTCH1 mediates a switch between two distinct secretomes during senescence. Nat. Cell Biol. 18, 979\u2013992 (2016).","journal-title":"Nat. Cell Biol."},{"key":"1123_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2024.1448543","volume":"5","author":"R-L Scanlan","year":"2024","unstructured":"Scanlan, R.-L. et al. Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence. Front. Aging 5, 1448543 (2024).","journal-title":"Front. Aging"},{"key":"1123_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102824","volume":"111","author":"MG Basilicata","year":"2025","unstructured":"Basilicata, M. G. et al. Multi-omics strategies to decode the molecular landscape of cellular senescence. Ageing Res. Rev. 111, 102824 (2025).","journal-title":"Ageing Res. Rev."},{"key":"1123_CR49","doi-asserted-by":"publisher","first-page":"F1486","DOI":"10.1152\/ajprenal.00378.2010","volume":"299","author":"JM Wolstein","year":"2010","unstructured":"Wolstein, J. M. et al. INK4a knockout mice exhibit increased fibrosis under normal conditions and in response to unilateral ureteral obstruction. Am. J. Physiol. Renal Physiol. 299, F1486\u2013F1495 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1123_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrneph.2016.183","volume":"13","author":"I Sturmlechner","year":"2017","unstructured":"Sturmlechner, I., Durik, M., Sieben, C. J., Baker, D. J. & van Deursen, J. M. Cellular senescence in renal ageing and disease. Nat. Rev. Nephrol. 13, 77\u201389 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"1123_CR51","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","volume":"31","author":"M Demaria","year":"2014","unstructured":"Demaria, M. et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31, 722\u2013733 (2014).","journal-title":"Dev. Cell"},{"key":"1123_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb3420","volume":"374","author":"I Sturmlechner","year":"2021","unstructured":"Sturmlechner, I. et al. p21 produces a bioactive secretome that places stressed cells under immunosurveillance. Science 374, eabb3420 (2021).","journal-title":"Science"},{"key":"1123_CR53","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/sj.ki.5002039","volume":"71","author":"B Sis","year":"2007","unstructured":"Sis, B. et al. Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease. Kidney Int. 71, 218\u2013226 (2007).","journal-title":"Kidney Int."},{"key":"1123_CR54","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1600-6143.2005.00846.x","volume":"5","author":"A Melk","year":"2005","unstructured":"Melk, A., Schmidt, B. M. W., Vongwiwatana, A., Rayner, D. C. & Halloran, P. F. Increased expression of senescence-associated cell cycle inhibitor p16 INK4a in deteriorating renal transplants and diseased native kidney. Am. J. Transplant. 5, 1375\u20131382 (2005).","journal-title":"Am. J. Transplant."},{"key":"1123_CR55","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.trsl.2019.07.005","volume":"213","author":"SR Kim","year":"2019","unstructured":"Kim, S. R. et al. Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin. Transl. Res. 213, 112\u2013123 (2019).","journal-title":"Transl. Res."},{"key":"1123_CR56","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202402558R","volume":"39","author":"Y Gan","year":"2025","unstructured":"Gan, Y. et al. Senolytic procyanidin C1 alleviates renal fibrosis by promoting apoptosis of senescent renal tubular epithelial cells. FASEB J. 39, e70362 (2025).","journal-title":"FASEB J."},{"key":"1123_CR57","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1248\/bpb.b22-00322","volume":"45","author":"A Sanagawa","year":"2022","unstructured":"Sanagawa, A. et al. Effect of replicative senescence on the expression and function of transporters in human proximal renal tubular epithelial cells. Biol. Pharm. Bull. 45, 1636\u20131643 (2022).","journal-title":"Biol. Pharm. Bull."},{"key":"1123_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1018298","volume":"9","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. Senescent renal tubular epithelial cells activate fibroblasts by secreting Shh to promote the progression of diabetic kidney disease. Front. Med. 9, 1018298 (2023).","journal-title":"Front. Med."},{"key":"1123_CR59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbrc.2019.07.024","volume":"517","author":"T Inoue","year":"2019","unstructured":"Inoue, T., Kusano, T., Amano, H., Nakamoto, H. & Okada, H. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease. Biochem. Biophys. Res. Commun. 517, 96\u2013102 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1123_CR60","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90299","volume":"2","author":"C Gerarduzzi","year":"2017","unstructured":"Gerarduzzi, C. et al. Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation. JCI Insight 2, e90299 (2017).","journal-title":"JCI Insight"},{"key":"1123_CR61","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41581-021-00474-8","volume":"17","author":"S Avraham","year":"2021","unstructured":"Avraham, S., Korin, B., Chung, J.-J., Oxburgh, L. & Shaw, A. S. The mesangial cell \u2014 the glomerular stromal cell. Nat. Rev. Nephrol. 17, 855\u2013864 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"1123_CR62","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/ki.2008.500","volume":"74","author":"L Li","year":"2008","unstructured":"Li, L. et al. The chemokine receptors CCR2 and CX3CR1 mediate monocyte\/macrophage trafficking in kidney ischemia\u2013reperfusion injury. Kidney Int. 74, 1526\u20131537 (2008).","journal-title":"Kidney Int."},{"key":"1123_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700790","volume":"12","author":"RA Campbell","year":"2021","unstructured":"Campbell, R. A., Docherty, M.-H., Ferenbach, D. A. & Mylonas, K. J. The role of ageing and parenchymal senescence on macrophage function and fibrosis. Front. Immunol. 12, 700790 (2021).","journal-title":"Front. Immunol."},{"key":"1123_CR64","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm.3218","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu, V. S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19, 1047\u20131053 (2013).","journal-title":"Nat. Med."},{"key":"1123_CR65","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1681\/ASN.2016050573","volume":"28","author":"Y-Y Wang","year":"2017","unstructured":"Wang, Y.-Y. et al. Macrophage-to-myofibroblast transition contributes to interstitial fibrosis in chronic renal allograft injury. J. Am. Soc. Nephrol. 28, 2053\u20132067 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1123_CR66","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99561","volume":"3","author":"R Kramann","year":"2018","unstructured":"Kramann, R. et al. Parabiosis and single-cell RNA sequencing reveal a limited contribution of monocytes to myofibroblasts in kidney fibrosis. JCI Insight 3, e99561 (2018).","journal-title":"JCI Insight"},{"key":"1123_CR67","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2941-1","volume":"589","author":"C Kuppe","year":"2021","unstructured":"Kuppe, C. et al. Decoding myofibroblast origins in human kidney fibrosis. Nature 589, 281\u2013286 (2021).","journal-title":"Nature"},{"key":"1123_CR68","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1172\/JCI0215518","volume":"110","author":"M Iwano","year":"2002","unstructured":"Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Investig. 110, 341\u2013350 (2002).","journal-title":"J. Clin. Investig."},{"key":"1123_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.814497","volume":"8","author":"MJ Moeller","year":"2022","unstructured":"Moeller, M. J. et al. New aspects of kidney fibrosis \u2014 from mechanisms of injury to modulation of disease. Front. Med. 8, 814497 (2022).","journal-title":"Front. Med."},{"key":"1123_CR70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","volume":"176","author":"BD Humphreys","year":"2010","unstructured":"Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85\u201397 (2010).","journal-title":"Am. J. Pathol."},{"key":"1123_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.569322","volume":"11","author":"L Sheng","year":"2020","unstructured":"Sheng, L. & Zhuang, S. New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis. Front. Physiol. 11, 569322 (2020).","journal-title":"Front. Physiol."},{"key":"1123_CR72","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.tem.2016.06.004","volume":"27","author":"S Lovisa","year":"2016","unstructured":"Lovisa, S., Zeisberg, M. & Kalluri, R. Partial epithelial-to-mesenchymal transition and other new mechanisms of kidney fibrosis. Trends Endocrinol. Metab. 27, 681\u2013695 (2016).","journal-title":"Trends Endocrinol. Metab."},{"key":"1123_CR73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12307-011-0069-4","volume":"5","author":"R-M Laberge","year":"2012","unstructured":"Laberge, R.-M., Awad, P., Campisi, J. & Desprez, P.-Y. Epithelial-mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron. 5, 39\u201344 (2012).","journal-title":"Cancer Microenviron."},{"key":"1123_CR74","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nm.3901","volume":"21","author":"MT Grande","year":"2015","unstructured":"Grande, M. T. et al. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat. Med. 21, 989\u2013997 (2015).","journal-title":"Nat. Med."},{"key":"1123_CR75","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3902","volume":"21","author":"S Lovisa","year":"2015","unstructured":"Lovisa, S. et al. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat. Med. 21, 998\u20131009 (2015).","journal-title":"Nat. Med."},{"key":"1123_CR76","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1159\/000100492","volume":"105","author":"I Niculescu-Duvaz","year":"2007","unstructured":"Niculescu-Duvaz, I., Phanish, M. K., Colville-Nash, P. & Dockrell, M. E. C. The TGF\u03b21-induced fibronectin in human renal proximal tubular epithelial cells is p38 MAP kinase dependent and Smad independent. Nephron Exp. Nephrol. 105, e108\u2013e116 (2007).","journal-title":"Nephron Exp. Nephrol."},{"key":"1123_CR77","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1159\/000443445","volume":"41","author":"X-X Pang","year":"2016","unstructured":"Pang, X.-X. et al. Urotensin II induces ER stress and EMT and increase extracellular matrix production in renal tubular epithelial cell in early diabetic mice. Kidney Blood Press. Res. 41, 434\u2013449 (2016).","journal-title":"Kidney Blood Press. Res."},{"key":"1123_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147018","volume":"11","author":"L Guo","year":"2016","unstructured":"Guo, L. et al. Hydrogen sulfide inhibits transforming growth factor-\u03b21-induced EMT via Wnt\/catenin pathway. PLoS ONE 11, e0147018 (2016).","journal-title":"PLoS ONE"},{"key":"1123_CR79","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3109\/0886022X.2014.967699","volume":"37","author":"Z Yang","year":"2015","unstructured":"Yang, Z. et al. Connective tissue growth factor induces tubular epithelial to mesenchymal transition through the activation of canonical Wnt signaling in vitro. Ren. Fail. 37, 129\u2013135 (2015).","journal-title":"Ren. Fail."},{"key":"1123_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0455-y","volume":"17","author":"W Hong","year":"2019","unstructured":"Hong, W. et al. Epithelial and interstitial Notch1 activity contributes to the myofibroblastic phenotype and fibrosis. Cell Commun. Signal. 17, 145 (2019).","journal-title":"Cell Commun. Signal."},{"key":"1123_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59997-4","volume":"16","author":"M Reck","year":"2025","unstructured":"Reck, M. et al. Multiomic analysis of human kidney disease identifies a tractable inflammatory and pro-fibrotic tubular cell phenotype. Nat. Commun. 16, 4745 (2025).","journal-title":"Nat. Commun."},{"key":"1123_CR82","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q Yu","year":"2000","unstructured":"Yu, Q. & Stamenkovic, I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-\u03b2 and promotes tumor invasion and angiogenesis. Genes. Dev. 14, 163\u2013176 (2000).","journal-title":"Genes. Dev."},{"key":"1123_CR83","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1038\/s44318-024-00246-7","volume":"43","author":"N Papismadov","year":"2024","unstructured":"Papismadov, N. et al. p21 regulates expression of ECM components and promotes pulmonary fibrosis via CDK4 and Rb. EMBO J. 43, 5360\u20135380 (2024).","journal-title":"EMBO J."},{"key":"1123_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13192-4","volume":"10","author":"O Karin","year":"2019","unstructured":"Karin, O., Agrawal, A., Porat, Z., Krizhanovsky, V. & Alon, U. Senescent cell turnover slows with age providing an explanation for the Gompertz law. Nat. Commun. 10, 5495 (2019).","journal-title":"Nat. Commun."},{"key":"1123_CR85","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mad.2017.08.005","volume":"170","author":"G Nelson","year":"2018","unstructured":"Nelson, G., Kucheryavenko, O., Wordsworth, J. & von Zglinicki, T. The senescent bystander effect is caused by ROS-activated NF-\u03baB signalling. Mech. Ageing Dev. 170, 30\u201336 (2018).","journal-title":"Mech. Ageing Dev."},{"key":"1123_CR86","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978\u2013990 (2013).","journal-title":"Nat. Cell Biol."},{"key":"1123_CR87","volume":"6","author":"MC Alfonzo","year":"2022","unstructured":"Alfonzo, M. C., Saedi, A. A., Fulzele, S. & Hamrick, M. W. Extracellular vesicles as communicators of senescence in musculoskeletal aging. J. Bone Miner. Res. Plus 6, e10686 (2022).","journal-title":"J. Bone Miner. Res. Plus"},{"key":"1123_CR88","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.166643","volume":"8","author":"S Li","year":"2023","unstructured":"Li, S. et al. Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity. JCI Insight 8, e166643 (2023).","journal-title":"JCI Insight"},{"key":"1123_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34660-4","volume":"13","author":"L Xu","year":"2022","unstructured":"Xu, L. et al. IL-33 induces thymic involution-associated naive T cell aging and impairs host control of severe infection. Nat. Commun. 13, 6881 (2022).","journal-title":"Nat. Commun."},{"key":"1123_CR90","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/s41590-024-01915-9","volume":"25","author":"AI Kousa","year":"2024","unstructured":"Kousa, A. I. et al. Age-related epithelial defects limit thymic function and regeneration. Nat. Immunol. 25, 1593\u20131606 (2024).","journal-title":"Nat. Immunol."},{"key":"1123_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02005-w","volume":"9","author":"S Chen","year":"2024","unstructured":"Chen, S., Zhu, H. & Jounaidi, Y. Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. Signal. Transduct. Target. Ther. 9, 302 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1123_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04562-w","volume":"13","author":"Z Bai","year":"2022","unstructured":"Bai, Z. et al. Combining adoptive NK cell infusion with a dopamine-releasing peptide reduces senescent cells in aged mice. Cell Death Dis. 13, 305 (2022).","journal-title":"Cell Death Dis."},{"key":"1123_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07825-3","volume":"9","author":"Y Ovadya","year":"2018","unstructured":"Ovadya, Y. et al. Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nat. Commun. 9, 5435 (2018).","journal-title":"Nat. Commun."},{"key":"1123_CR94","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-021-03547-7","volume":"594","author":"MJ Yousefzadeh","year":"2021","unstructured":"Yousefzadeh, M. J. et al. An aged immune system drives senescence and ageing of solid organs. Nature 594, 100\u2013105 (2021).","journal-title":"Nature"},{"key":"1123_CR95","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adv4071","volume":"17","author":"Y Arai","year":"2025","unstructured":"Arai, Y. et al. Hematopoietic loss of Y chromosome activates immune checkpoints and contributes to impaired senescent cell clearance and renal disease. Sci. Transl. Med. 17, eadv4071 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1123_CR96","doi-asserted-by":"publisher","first-page":"328","DOI":"10.18632\/aging.100897","volume":"8","author":"A Sagiv","year":"2016","unstructured":"Sagiv, A. et al. NKG2D ligands mediate immunosurveillance of senescent cells. Aging 8, 328\u2013344 (2016).","journal-title":"Aging"},{"key":"1123_CR97","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202207097","volume":"222","author":"D Schloesser","year":"2022","unstructured":"Schloesser, D. et al. Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT\/L axis. J. Cell Biol. 222, e202207097 (2022).","journal-title":"J. Cell Biol."},{"key":"1123_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10335-5","volume":"10","author":"BI Pereira","year":"2019","unstructured":"Pereira, B. I. et al. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition. Nat. Commun. 10, 2387 (2019).","journal-title":"Nat. Commun."},{"key":"1123_CR99","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41586-022-05388-4","volume":"611","author":"T-W Wang","year":"2022","unstructured":"Wang, T.-W. et al. Blocking PD-L1\u2013PD-1 improves senescence surveillance and ageing phenotypes. Nature 611, 358\u2013364 (2022).","journal-title":"Nature"},{"key":"1123_CR100","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2012.12.010","volume":"152","author":"CE Burd","year":"2013","unstructured":"Burd, C. E. et al. Monitoring tumorigenesis and senescence in vivo with a p16 INK4a-luciferase model. Cell 152, 340\u2013351 (2013).","journal-title":"Cell"},{"key":"1123_CR101","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s11357-020-00185-1","volume":"42","author":"MJ Yousefzadeh","year":"2020","unstructured":"Yousefzadeh, M. J. et al. Heterochronic parabiosis regulates the extent of cellular senescence in multiple tissues. GeroScience 42, 951\u2013961 (2020).","journal-title":"GeroScience"},{"key":"1123_CR102","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11357-020-00286-x","volume":"43","author":"O Karin","year":"2021","unstructured":"Karin, O. & Alon, U. Senescent cell accumulation mechanisms inferred from parabiosis. GeroScience 43, 329\u2013341 (2021).","journal-title":"GeroScience"},{"key":"1123_CR103","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14297","volume":"23","author":"K Abdelmohsen","year":"2024","unstructured":"Abdelmohsen, K. et al. Identification of senescent cell subpopulations by CITE-seq analysis. Aging Cell 23, e14297 (2024).","journal-title":"Aging Cell"},{"key":"1123_CR104","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1016\/j.cell.2024.05.059","volume":"187","author":"M Ogrodnik","year":"2024","unstructured":"Ogrodnik, M. et al. Guidelines for minimal information on cellular senescence experimentation in vivo. Cell 187, 4150\u20134175 (2024).","journal-title":"Cell"},{"key":"1123_CR105","doi-asserted-by":"publisher","first-page":"39512","DOI":"10.18632\/oncotarget.17080","volume":"8","author":"Y Nakamura","year":"2017","unstructured":"Nakamura, Y. et al. A topically-sprayable, activatable fluorescent and retaining probe, SPiDER-\u03b2Gal for detecting cancer: advantages of anchoring to cellular proteins after activation. Oncotarget 8, 39512\u201339521 (2017).","journal-title":"Oncotarget"},{"key":"1123_CR106","doi-asserted-by":"publisher","DOI":"10.3791\/58133","author":"H Fuhrmann-Stroissnigg","year":"2019","unstructured":"Fuhrmann-Stroissnigg, H. et al. SA-\u03b2-galactosidase-based screening assay for the identification of senotherapeutic drugs. J. Vis. Exp. https:\/\/doi.org\/10.3791\/58133 (2019).","journal-title":"J. Vis. Exp."},{"key":"1123_CR107","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18632\/aging.100527","volume":"5","author":"E Georgakopoulou","year":"2012","unstructured":"Georgakopoulou, E. et al. Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues. Aging 5, 37\u201350 (2012).","journal-title":"Aging"},{"key":"1123_CR108","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1016\/j.molcel.2023.09.006","volume":"83","author":"S Magkouta","year":"2023","unstructured":"Magkouta, S. et al. A fluorophore-conjugated reagent enabling rapid detection, isolation and live tracking of senescent cells. Mol. Cell 83, 3558\u20133573.e7 (2023).","journal-title":"Mol. Cell"},{"key":"1123_CR109","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1128\/MCB.05243-11","volume":"31","author":"KL Tinkum","year":"2011","unstructured":"Tinkum, K. L. et al. Bioluminescence imaging captures the expression and dynamics of endogenous p21 promoter activity in living mice and intact cells. Mol. Cell. Biol. 31, 3759\u20133772 (2011).","journal-title":"Mol. Cell. Biol."},{"key":"1123_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34801-9","volume":"13","author":"J Sun","year":"2022","unstructured":"Sun, J. et al. A Glb1-2A-mCherry reporter monitors systemic aging and predicts lifespan in middle-aged mice. Nat. Commun. 13, 7028 (2022).","journal-title":"Nat. Commun."},{"key":"1123_CR111","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154124","volume":"7","author":"ED O\u2019Sullivan","year":"2022","unstructured":"O\u2019Sullivan, E. D. et al. Single-cell analysis of senescent epithelia reveals targetable mechanisms promoting fibrosis. JCI Insight 7, e154124 (2022).","journal-title":"JCI Insight"},{"key":"1123_CR112","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1681\/ASN.2020091373","volume":"32","author":"SR Kim","year":"2021","unstructured":"Kim, S. R. et al. Progressive cellular senescence mediates renal dysfunction in ischemic nephropathy. J. Am. Soc. Nephrol. 32, 1987\u20132004 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1123_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16060695","volume":"16","author":"T Li","year":"2024","unstructured":"Li, T. et al. Targeted drug therapy for senescent cells alleviates unilateral ureteral obstruction-induced renal injury in rats. Pharmaceutics 16, 695 (2024).","journal-title":"Pharmaceutics"},{"key":"1123_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094401","volume":"26","author":"L Tejedor-Santamaria","year":"2025","unstructured":"Tejedor-Santamaria, L. et al. CCN2 activates cellular senescence leading to kidney fibrosis in folic acid-induced experimental nephropathy. Int. J. Mol. Sci. 26, 4401 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"1123_CR115","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.stem.2008.01.014","volume":"2","author":"BD Humphreys","year":"2008","unstructured":"Humphreys, B. D. et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2, 284\u2013291 (2008).","journal-title":"Cell Stem Cell"},{"key":"1123_CR116","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008300","volume":"4","author":"MH Little","year":"2012","unstructured":"Little, M. H. & McMahon, A. P. Mammalian kidney development: principles, progress, and projections. Cold Spring Harb. Perspect. Biol. 4, a008300 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1123_CR117","doi-asserted-by":"publisher","first-page":"15874","DOI":"10.1073\/pnas.2005477117","volume":"117","author":"Y Kirita","year":"2020","unstructured":"Kirita, Y., Wu, H., Uchimura, K., Wilson, P. C. & Humphreys, B. D. Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury. Proc. Natl. Acad. Sci. 117, 15874\u201315883 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1123_CR118","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.94716","volume":"2","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Molecular characterization of the transition from acute to chronic kidney injury following ischemia\/reperfusion. JCI Insight 2, e94716 (2017).","journal-title":"JCI Insight"},{"key":"1123_CR119","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/ndt\/gfae030","volume":"39","author":"K Abdank","year":"2024","unstructured":"Abdank, K. et al. A comparative scRNAseq data analysis to match mouse models with human kidney disease at the molecular level. Nephrol. Dial. Transplant. 39, 1044\u20131047 (2024).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1123_CR120","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1681\/ASN.2016101150","volume":"29","author":"M Swaminathan","year":"2018","unstructured":"Swaminathan, M. et al. Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery. J. Am. Soc. Nephrol. 29, 260\u2013267 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1123_CR121","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ekir.2017.03.016","volume":"2","author":"S Demirjian","year":"2017","unstructured":"Demirjian, S. et al. Safety and tolerability study of an intravenously administered small interfering ribonucleic acid (siRNA) post on-pump cardiothoracic surgery in patients at risk of acute kidney injury. Kidney Int. Rep. 2, 836\u2013843 (2017).","journal-title":"Kidney Int. Rep."},{"key":"1123_CR122","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003549","volume":"5","author":"PA McCullough","year":"2016","unstructured":"McCullough, P. A. et al. ABT-719 for the prevention of acute kidney injury in patients undergoing high-risk cardiac surgery: a randomized phase 2b clinical trial. J. Am. Hear. Assoc. 5, e003549 (2016).","journal-title":"J. Am. Hear. Assoc."},{"key":"1123_CR123","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00134-023-07271-w","volume":"50","author":"P Pickkers","year":"2024","unstructured":"Pickkers, P. et al. Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL). Intensiv. Care Med. 50, 68\u201378 (2024).","journal-title":"Intensiv. Care Med."},{"key":"1123_CR124","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000486398","volume":"47","author":"MP Chin","year":"2018","unstructured":"Chin, M. P. et al. Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes: post-hoc analyses from bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes study. Am. J. Nephrol. 47, 40\u201347 (2018).","journal-title":"Am. J. Nephrol."},{"key":"1123_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002667","volume":"22","author":"BV Ineichen","year":"2024","unstructured":"Ineichen, B. V., Furrer, E., Gr\u00fcninger, S. L., Z\u00fcrrer, W. E. & Macleod, M. R. Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications. PLoS Biol. 22, e3002667 (2024).","journal-title":"PLoS Biol."},{"key":"1123_CR126","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41580-024-00800-5","volume":"26","author":"C Jones-Weinert","year":"2025","unstructured":"Jones-Weinert, C., Mainz, L. & Karlseder, J. Telomere function and regulation from mouse models to human ageing and disease. Nat. Rev. Mol. Cell Biol. 26, 297\u2013313 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1123_CR127","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41581-022-00598-5","volume":"18","author":"J Schnell","year":"2022","unstructured":"Schnell, J., Achieng, M. & Lindstr\u00f6m, N. O. Principles of human and mouse nephron development. Nat. Rev. Nephrol. 18, 628\u2013642 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1123_CR128","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/ajt.16868","volume":"22","author":"LJS Lerink","year":"2022","unstructured":"Lerink, L. J. S. et al. Preclinical models versus clinical renal ischemia reperfusion injury: a systematic review based on metabolic signatures. Am. J. Transplant. 22, 344\u2013370 (2022).","journal-title":"Am. J. Transplant."},{"key":"1123_CR129","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1681\/ASN.0000000000000217","volume":"34","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. Unified mouse and human kidney single-cell expression atlas reveal commonalities and differences in disease states. J. Am. Soc. Nephrol. 34, 1843\u20131862 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1123_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032827","volume":"24","author":"U Rende","year":"2023","unstructured":"Rende, U. et al. Deciphering the kidney matrisome: identification and quantification of renal extracellular matrix proteins in healthy mice. Int. J. Mol. Sci. 24, 2827 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1123_CR131","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1242\/dev.127175","volume":"143","author":"LL O\u2019Brien","year":"2016","unstructured":"O\u2019Brien, L. L. et al. Differential regulation of mouse and human nephron progenitors by the Six family of transcriptional regulators. Development 143, 595\u2013608 (2016).","journal-title":"Development"},{"key":"1123_CR132","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s43587-024-00752-7","volume":"5","author":"CM Carver","year":"2025","unstructured":"Carver, C. M. et al. IL-23R is a senescence-linked circulating and tissue biomarker of aging. Nat. Aging 5, 291\u2013305 (2025).","journal-title":"Nat. Aging"},{"key":"1123_CR133","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s43587-021-00151-2","volume":"1","author":"M Suda","year":"2021","unstructured":"Suda, M. et al. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. Nat. Aging 1, 1117\u20131126 (2021).","journal-title":"Nat. Aging"},{"key":"1123_CR134","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1007\/s11357-024-01504-6","volume":"47","author":"A Gadecka","year":"2025","unstructured":"Gadecka, A. et al. The senolytic cocktail, dasatinib and quercetin, impacts the chromatin structure of both young and senescent vascular smooth muscle cells. GeroScience 47, 3907\u20133925 (2025).","journal-title":"GeroScience"},{"key":"1123_CR135","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson, L. J. et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine 47, 446\u2013456 (2019).","journal-title":"EBioMedicine"},{"key":"1123_CR136","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","volume":"380","author":"V Perkovic","year":"2019","unstructured":"Perkovic, V. et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N. Engl. J. Med. 380, 2295\u20132306 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1123_CR137","first-page":"117","volume":"388","author":"TE-KC Group","year":"2022","unstructured":"Group, T. E.-K. C. et al. Empagliflozin in patients with chronic kidney disease. N. Engl. J. Med. 388, 117\u2013127 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1123_CR138","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/S0140-6736(23)02230-4","volume":"402","author":"HJL Heerspink","year":"2023","unstructured":"Heerspink, H. J. L. et al. Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial. Lancet 402, 2004\u20132017 (2023).","journal-title":"Lancet"},{"key":"1123_CR139","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1111\/dom.14503","volume":"23","author":"MN Kim","year":"2021","unstructured":"Kim, M. N., Moon, J. H. & Cho, Y. M. Sodium-glucose cotransporter-2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body-induced NRF2 activation. Diabetes Obes. Metab. 23, 2561\u20132571 (2021).","journal-title":"Diabetes Obes. Metab."},{"key":"1123_CR140","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","volume":"32","author":"I Tomita","year":"2020","unstructured":"Tomita, I. et al. SGLT2 inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition. Cell Metab. 32, 404\u2013419.e6 (2020).","journal-title":"Cell Metab."},{"key":"1123_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-025-00227-y","volume":"11","author":"ZE Yesilyurt-Dirican","year":"2025","unstructured":"Yesilyurt-Dirican, Z. E. et al. SGLT2 inhibitors as a novel senotherapeutic approach. NPJ Aging 11, 35 (2025).","journal-title":"NPJ Aging"},{"key":"1123_CR142","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/ndt\/gfad183","volume":"39","author":"HJL Heerspink","year":"2023","unstructured":"Heerspink, H. J. L. et al. Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial. Nephrol. Dial. Transplant. 39, 414\u2013425 (2023).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1123_CR143","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/febs.16350","volume":"290","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Pitcher, L. E., Prahalad, V., Niedernhofer, L. J. & Robbins, P. D. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J. 290, 1362\u20131383 (2023).","journal-title":"FEBS J."},{"key":"1123_CR144","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13142","volume":"19","author":"E Gonz\u00e1lez-Gualda","year":"2020","unstructured":"Gonz\u00e1lez-Gualda, E. et al. Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity. Aging Cell 19, e13142 (2020).","journal-title":"Aging Cell"},{"key":"1123_CR145","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1111\/ajt.17102","volume":"22","author":"CM Liao","year":"2022","unstructured":"Liao, C. M. et al. Induction of ferroptosis selectively eliminates senescent tubular cells. Am. J. Transplant. 22, 2158\u20132168 (2022).","journal-title":"Am. J. Transplant."},{"key":"1123_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.960601","volume":"13","author":"S Ijima","year":"2022","unstructured":"Ijima, S. et al. Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis. Front. Immunol. 13, 960601 (2022).","journal-title":"Front. Immunol."},{"key":"1123_CR147","first-page":"325","volume":"42","author":"HY Ju","year":"2023","unstructured":"Ju, H. Y., Kim, J. & Han, S. J. The flavonoid fisetin ameliorates renal fibrosis by inhibiting SMAD3 phosphorylation, oxidative damage, and inflammation in ureteral obstructed kidney in mice. Korean J. Nephrol. 42, 325\u2013339 (2023).","journal-title":"Korean J. Nephrol."},{"key":"1123_CR148","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cell.2017.02.031","volume":"169","author":"MP Baar","year":"2017","unstructured":"Baar, M. P. et al. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 169, 132\u2013147.e16 (2017).","journal-title":"Cell"},{"key":"1123_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-024-00138-4","volume":"10","author":"V Lelarge","year":"2024","unstructured":"Lelarge, V., Capelle, R., Oger, F., Mathieu, T. & Calv\u00e9, B. L. Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients\u2019 treatment. NPJ Aging 10, 12 (2024).","journal-title":"NPJ Aging"},{"key":"1123_CR150","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s42255-019-0122-z","volume":"1","author":"A Guerrero","year":"2019","unstructured":"Guerrero, A. et al. Cardiac glycosides are broad-spectrum senolytics. Nat. Metab. 1, 1074\u20131088 (2019).","journal-title":"Nat. Metab."},{"key":"1123_CR151","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1126\/science.abb5916","volume":"371","author":"Y Johmura","year":"2021","unstructured":"Johmura, Y. et al. Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders. Science 371, 265\u2013270 (2021).","journal-title":"Science"},{"key":"1123_CR152","doi-asserted-by":"publisher","DOI":"10.1172\/JCI156250","volume":"132","author":"JW Pippin","year":"2022","unstructured":"Pippin, J. W. et al. Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease. J. Clin. Investig. 132, e156250 (2022).","journal-title":"J. Clin. Investig."},{"key":"1123_CR153","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2020.05.002","volume":"32","author":"L Grosse","year":"2020","unstructured":"Grosse, L. et al. Defined p16High senescent cell types are indispensable for mouse healthspan. Cell Metab. 32, 87\u201399.e6 (2020).","journal-title":"Cell Metab."},{"key":"1123_CR154","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1097\/01.ASN.0000130564.75008.F5","volume":"15","author":"V ESTEBAN","year":"2004","unstructured":"ESTEBAN, V. et al. Angiotensin II, via B AT1 and AT2 receptors and NF-\u03baB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J. Am. Soc. Nephrol. 15, 1514\u20131529 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1123_CR155","doi-asserted-by":"publisher","first-page":"F155","DOI":"10.1152\/ajprenal.00491.2012","volume":"305","author":"C Okabe","year":"2013","unstructured":"Okabe, C. et al. NF-\u03baB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy. Am. J. Physiol. Renal Physiol. 305, F155\u2013F163 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1123_CR156","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3760\/cma.j.issn.0366-6999.20132781","volume":"127","author":"J Gu","year":"2014","unstructured":"Gu, J., Ye, S., Wang, S., Sun, W. & Hu, Y. Metformin inhibits nuclear factor-\u03baB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro. Chin. Med. J. 127, 1755\u20131760 (2014).","journal-title":"Chin. Med. J."},{"key":"1123_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.926211","volume":"13","author":"D Liang","year":"2022","unstructured":"Liang, D. et al. Metformin improves the senescence of renal tubular epithelial cells in a high-glucose state through E2F1. Front. Pharmacol. 13, 926211 (2022).","journal-title":"Front. Pharmacol."},{"key":"1123_CR158","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/acel.12587","volume":"16","author":"R Wang","year":"2017","unstructured":"Wang, R. et al. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism. Aging Cell 16, 564\u2013574 (2017).","journal-title":"Aging Cell"},{"key":"1123_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125469","volume":"674","author":"W Zhou","year":"2025","unstructured":"Zhou, W. et al. Glutaminase-responsive nano-carrier for precise rejuvenation of senescent cells by restoring autophagy in chronic kidney disease treatment. Int. J. Pharm. 674, 125469 (2025).","journal-title":"Int. J. Pharm."},{"key":"1123_CR160","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz, G. et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 830\u2013840 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1123_CR161","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2215\/CJN.02650313","volume":"9","author":"WE Braun","year":"2014","unstructured":"Braun, W. E., Schold, J. D., Stephany, B. R., Spirko, R. A. & Herts, B. R. Low-dose papamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study. Clin. J. Am. Soc. Nephrol. 9, 881\u2013888 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1123_CR162","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000485845","volume":"47","author":"T Sofue","year":"2018","unstructured":"Sofue, T. et al. Tubular cell senescence in the donated kidney predicts allograft function, but not donor remnant kidney function, in living donor kidney transplantation. Am. J. Nephrol. 47, 8\u201317 (2018).","journal-title":"Am. J. Nephrol."},{"key":"1123_CR163","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1474-9726.2008.00447.x","volume":"8","author":"LM McGlynn","year":"2009","unstructured":"McGlynn, L. M. et al. Cellular senescence in pretransplant renal biopsies predicts postoperative organ function. Aging Cell 8, 45\u201351 (2009).","journal-title":"Aging Cell"},{"key":"1123_CR164","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41591-023-02376-7","volume":"29","author":"SA Hosgood","year":"2023","unstructured":"Hosgood, S. A. et al. Normothermic machine perfusion versus static cold storage in donation after circulatory death kidney transplantation: a randomized controlled trial. Nat. Med. 29, 1511\u20131519 (2023).","journal-title":"Nat. Med."},{"key":"1123_CR165","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znab282.008","volume":"108","author":"ER Thompson","year":"2021","unstructured":"Thompson, E. R. et al. O3 Ex vivo normothermic machine perfusion facilitates gymnotic delivery of RNA interference therapeutics in donor kidneys. Br. J. Surg. 108, znab282.008 (2021).","journal-title":"Br. J. Surg."},{"key":"1123_CR166","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232\u2013236 (2011).","journal-title":"Nature"},{"key":"1123_CR167","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s11357-023-00829-y","volume":"46","author":"AT Fard","year":"2024","unstructured":"Fard, A. T. et al. Deconstructing heterogeneity of replicative senescence in human mesenchymal stem cells at single cell resolution. GeroScience 46, 999\u20131015 (2024).","journal-title":"GeroScience"},{"key":"1123_CR168","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232136","volume":"221","author":"M Reimann","year":"2024","unstructured":"Reimann, M., Lee, S. & Schmitt, C. A. Cellular senescence: neither irreversible nor reversible. J. Exp. Med. 221, e20232136 (2024).","journal-title":"J. Exp. Med."},{"key":"1123_CR169","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/s41556-023-01267-w","volume":"25","author":"J Gil","year":"2023","unstructured":"Gil, J. The challenge of identifying senescent cells. Nat. Cell Biol. 25, 1554\u20131556 (2023).","journal-title":"Nat. Cell Biol."},{"key":"1123_CR170","doi-asserted-by":"publisher","first-page":"101035","DOI":"10.1016\/j.xgen.2025.101035","volume":"5","author":"Y Qu","year":"2025","unstructured":"Qu, Y. et al. Single-cell and spatial detection of senescent cells using DeepScence. Cell Genom. 5, 101035 (2025).","journal-title":"Cell Genom."},{"key":"1123_CR171","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1007\/s11357-024-01485-6","volume":"47","author":"S Mahmud","year":"2025","unstructured":"Mahmud, S. et al. A machine learning approach identifies cellular senescence on transcriptome data of human cells in vitro. GeroScience 47, 5287\u20135301 (2025).","journal-title":"GeroScience"},{"key":"1123_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14976-9","volume":"11","author":"P Qiu","year":"2020","unstructured":"Qiu, P. Embracing the dropouts in single-cell RNA-seq analysis. Nat. Commun. 11, 1169 (2020).","journal-title":"Nat. Commun."},{"key":"1123_CR173","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","volume":"619","author":"BB Lake","year":"2023","unstructured":"Lake, B. B. et al. An atlas of healthy and injured cell states and niches in the human kidney. Nature 619, 585\u2013594 (2023).","journal-title":"Nature"},{"key":"1123_CR174","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.1021\/acs.jmedchem.4c00179","volume":"67","author":"X Xiang","year":"2024","unstructured":"Xiang, X. et al. Novel PET imaging probe for quantitative detection of senescence in vivo. J. Med. Chem. 67, 5924\u20135934 (2024).","journal-title":"J. Med. Chem."},{"key":"1123_CR175","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk5747","volume":"10","author":"HTM Nguyen","year":"2024","unstructured":"Nguyen, H. T. M. et al. Ultrasensitive and multiplexed tracking of single cells using whole-body PET\/CT. Sci. Adv. 10, eadk5747 (2024).","journal-title":"Sci. Adv."},{"key":"1123_CR176","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2171887","volume":"45","author":"B Jiang","year":"2023","unstructured":"Jiang, B., Liu, F., Fu, H. & Mao, J. Advances in imaging techniques to assess kidney fibrosis. Ren. Fail. 45, 2171887 (2023).","journal-title":"Ren. Fail."},{"key":"1123_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpblue.2026.100004","author":"LJ Zhang","year":"2026","unstructured":"Zhang, L. J. et al. Polyunsaturated lipid senolytics exploit a ferroptotic vulnerability in senescent cells. Cell Press Blue https:\/\/doi.org\/10.1016\/j.cpblue.2026.100004 (2026).","journal-title":"Cell Press Blue"},{"key":"1123_CR178","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2417724121","volume":"121","author":"GC Raffi","year":"2024","unstructured":"Raffi, G. C. et al. An antibiotic that mediates immune destruction of senescent cancer cells. Proc. Natl. Acad. Sci. 121, e2417724121 (2024).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1123_CR179","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.trsl.2011.11.008","volume":"159","author":"J Liu","year":"2012","unstructured":"Liu, J. et al. Accelerated senescence of renal tubular epithelial cells is associated with disease progression of patients with immunoglobulin A (IgA) nephropathy. Transl. Res. 159, 454\u2013463 (2012).","journal-title":"Transl. Res."},{"key":"1123_CR180","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/ckj\/sfad203","volume":"16","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Clinical and pathological characteristics in elderly patients with IgA nephropathy. Clin. Kidney J. 16, 1974\u20131979 (2023).","journal-title":"Clin. Kidney J."},{"key":"1123_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02650-2","volume":"11","author":"X Lu","year":"2025","unstructured":"Lu, X., Wu, J., Agborbesong, E. & Li, X. P16-positive senescent cells promote DKD by the dysregulation of glycolysis and mitochondrial metabolism. Cell Death Discov. 11, 355 (2025).","journal-title":"Cell Death Discov."},{"key":"1123_CR182","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-024-01156-w","volume":"38","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. High glucose induces renal tubular epithelial cell senescence by inhibiting autophagic flux. Hum. Cell 38, 43 (2025).","journal-title":"Hum. Cell"},{"key":"1123_CR183","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.107.099432","volume":"52","author":"JH Westhoff","year":"2008","unstructured":"Westhoff, J. H. et al. Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension 52, 123\u2013129 (2008).","journal-title":"Hypertension"},{"key":"1123_CR184","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1159\/000511560","volume":"51","author":"D Verzola","year":"2021","unstructured":"Verzola, D. et al. Cellular senescence is associated with faster progression of focal segmental glomerulosclerosis. Am. J. Nephrol. 51, 950\u2013958 (2021).","journal-title":"Am. J. Nephrol."},{"key":"1123_CR185","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.kint.2025.05.027","volume":"108","author":"X Mao","year":"2025","unstructured":"Mao, X. et al. Cellular senescence and its association with aldose reductase promote cyst growth in autosomal dominant polycystic kidney disease. Kidney Int. 108, 811\u2013826 (2025).","journal-title":"Kidney Int."},{"key":"1123_CR186","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001844","volume":"7","author":"G Tilman","year":"2021","unstructured":"Tilman, G. et al. High p16INK4a, a marker of cellular senescence, is associated with renal injury, impairment and outcome in lupus nephritis. RMD Open. 7, e001844 (2021).","journal-title":"RMD Open."},{"key":"1123_CR187","doi-asserted-by":"publisher","first-page":"e1528","DOI":"10.1038\/cddis.2014.489","volume":"5","author":"M Althubiti","year":"2014","unstructured":"Althubiti, M. et al. Characterization of novel markers of senescence and their prognostic potential in cancer. Cell Death Dis. 5, e1528\u2013e1528 (2014).","journal-title":"Cell Death Dis."},{"key":"1123_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99852-2","volume":"11","author":"M Poblocka","year":"2021","unstructured":"Poblocka, M. et al. Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker. Sci. Rep. 11, 20358 (2021).","journal-title":"Sci. Rep."},{"key":"1123_CR189","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13133","volume":"19","author":"A Guerrero","year":"2020","unstructured":"Guerrero, A. et al. Galactose-modified duocarmycin prodrugs as senolytics. Aging Cell 19, e13133 (2020).","journal-title":"Aging Cell"},{"key":"1123_CR190","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","volume":"583","author":"C Amor","year":"2020","unstructured":"Amor, C. et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583, 127\u2013132 (2020).","journal-title":"Nature"},{"key":"1123_CR191","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add1951","volume":"15","author":"D Yang","year":"2023","unstructured":"Yang, D. et al. NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates. Sci. Transl. Med. 15, eadd1951 (2023).","journal-title":"Sci. Transl. Med."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01123-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01123-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01123-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:02:21Z","timestamp":1790179341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01123-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":191,"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1038\/s41581-026-01123-8","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"21 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.A.F. has an ongoing collaboration with Argenx funding work unrelated to senescence and previously from GeneOne Life Sciences. He is listed as a co-inventor on a US Patent Office application describing novel urinary biomarkers of senescence. He has been a paid consultant for Boehringer Ingelheim,\u00a0Rejuvenon Therapeutics and Dorian Therapeutics, received honoraria for speaking at the ASN, ESOT and ERA, and has attended the scientific advisory board of UCB. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}